Events Inpatient Pharmacy Management 
Pharmacy Times
JUNE 24, 2025
And then into the outpatient and inpatient settings—are we treating the right patients in the inpatient setting that need to be treated? Then we filter that all the way down into the clinic, about how do we, you know, move patients in and out of the system? How are we advanced prepping drugs? Are we making sure things are going well?
Pharmacy Times
AUGUST 11, 2025
Transitions of care, or the movement of patients between health care settings or providers, impose a significant cost on the health care system due to frequent adverse events and hospital readmissions. Transitions of care in and out of inpatient settings are the most obvious and impactful and can be associated with adverse patient outcomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 27, 2025
Treatment-related adverse events (AEs) included nausea (77.8% vs 10.8%, respectively), and major bleeding events (2.4% 5 Primary end points included safety, with secondary end points of overall response rate (ORR), progression-free survival (PFS), and duration of response. ORRs were 94.4% in the TN cohort (95% CI, 72.7%-99.9%)
Pharmacy Times
JULY 25, 2025
Pneumococcal vaccination claims were identified from inpatient, outpatient, and pharmacy settings. The retrospective cohort study utilized individual-level data on vaccine uptake from the Centers for Medicare and Medicaid Services (CMS) and county-level data on social vulnerability from the CDC.
Pharmacy Times
JULY 24, 2025
Finerenone, a nonsteroidal MRA, shows promise in reducing HF events and atrial fibrillation, offering potential benefits over steroidal MRAs like spironolactone. Yet, despite growing awareness, HFpEF remains difficult to manage due to nonspecific symptoms, limited clinical trial data, and inconsistencies in diagnosis.
Pharmacy Times
JUNE 17, 2025
Medically integrated pharmacy (MIP) interventions using data from a cost avoidance and waste tracker tool show: The net cost avoidance for the MIPs was $6,510,971.28 for the external mail-order pharmacies. Among the 37 practices that reported waste, 768 events were reported, leading to a total drug waste of $11,275,642.16.
Pharmacy Times
JULY 2, 2025
So if patients are doing research about transplants, what they read and hear on the internet is that it’s all inpatient. What pharmacy is going to do it? Is it the inpatient pharmacy? Is it the outpatient pharmacy?” And so they're like, “What do you mean?” And then also just trying to find space.
Expert insights. Personalized for you.
Let's personalize your content